Fadi Towfic

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Blood · 2018 · 495 citations · Full text

Medicine, Molecular Biology, Oncology +12

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Leukemia · 2018 · 453 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN

Chad C. Bjorklund, Jian Kang, Michael Amatangelo et al. · Leukemia · 2019 · 196 citations · Full text

Medicine, Oncology, Pharmacology +15

Genetic Variants Synthesize to Produce Paneth Cell Phenotypes That Define Subtypes of Crohn's Disease

Kelli L. VanDussen, Ta‐Chiang Liu, Dalin Li et al. · Gastroenterology · 2013 · 189 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

Sarah Gooding, Naser Ansari‐Pour, Fadi Towfic et al. · Blood · 2020 · 159 citations · Full text

Medicine, Genetics, Molecular Genetics +14